Knowledge Management System of Institute of Zoology, CAS
Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors | |
Source Publication | JOURNAL OF CLINICAL ONCOLOGY |
2020 | |
Volume | 38Issue:15 |
Wang Zhenguang; Chen Meixia; Zhang Yan; Liu Yang; Yang Qingming; Nie Jing; Shen Lianjun; Jiang Pengfei; He Jiaping; Ye Xun; Cao Wei; Wang HY(王皓毅); Han Weidong | |
Document Type | 期刊论文 |
Identifier | http://ir.ioz.ac.cn/handle/000000/14558 |
Collection | 干细胞与生殖生物学国家重点实验室 |
Recommended Citation GB/T 7714 | Wang Zhenguang,Chen Meixia,Zhang Yan,et al. Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors[J]. JOURNAL OF CLINICAL ONCOLOGY,2020,38(15). |
APA | Wang Zhenguang.,Chen Meixia.,Zhang Yan.,Liu Yang.,Yang Qingming.,...&Han Weidong.(2020).Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors.JOURNAL OF CLINICAL ONCOLOGY,38(15). |
MLA | Wang Zhenguang,et al."Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors".JOURNAL OF CLINICAL ONCOLOGY 38.15(2020). |
Files in This Item: | Download All | |||||
File Name/Size | DocType | Version | Access | License | ||
Phase I study of CRI(454KB) | 期刊论文 | 出版稿 | 开放获取 | CC BY-NC-SA | View Download |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment